The CMV lytic marker is a term used in medical testing to detect the active phase of cytomegalovirus (CMV) infection. CMV is a common virus that belongs to the herpesvirus family, and while it can infect anyone, it often remains dormant in the body after the initial infection.
When the virus is in its lytic phase, it means that it is actively replicating and producing new virus particles, which can potentially cause symptoms or complications, especially in individuals with weakened immune systems, such as transplant recipients, people with HIV/AIDS, or those undergoing chemotherapy.
The presence of CMV in its lytic phase is typically assessed through various laboratory tests that measure specific markers or antigens associated with active viral replication. These tests might include PCR (polymerase chain reaction) tests that detect viral DNA in blood or tissues, or antigenemia assays that identify CMV antigens in white blood cells.
A positive "CMV lytic" result indicates that the virus is actively replicating, and this can prompt healthcare providers to initiate or adjust antiviral treatments to manage the infection and prevent further complications. Understanding the lytic phase of CMV is crucial because it highlights the periods when the virus can cause the most harm, particularly in vulnerable populations, and helps guide appropriate medical interventions to control the infection.
CMV lytic
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.